CCMH
ANIK icon

Cornerstone Capital Management Holdings’s Anika Therapeutics ANIK Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,500
Closed -$215K – 1327
2016
Q3 		$215K Sell
4,500
-8,100
-64% -$400K ﹤0.01% 1185
2016
Q2 		$676K Buy
+12,600
New +$594K 0.01% 970
2014
Q3 		– Sell
-200
Closed -$9K – 1266
2014
Q2 		$9K Buy
+200
New +$8.89K ﹤0.01% 1288

Other funds holding ANIK

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.57B AUM 19.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cornerstone Capital Management Holdings's ANIK Position: Q4 2016 in Review

Cornerstone Capital Management Holdings sold out of Anika Therapeutics (ANIK) in Q4 2016, closing a stake of 4,500 shares — an estimated $215K sold.

Cornerstone Capital Management Holdings first reported a position in ANIK in Q2 2014 and held it in 3 quarters. The position peaked at $676K in Q2 2016. 158 funds tracked by Wall St. Rank hold ANIK as of Q4 2016.

  • Cornerstone Capital Management Holdings reported no remaining Anika Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 4,500 Anika Therapeutics shares in Q4 2016, an estimated $215K.
  • Cornerstone Capital Management Holdings first reported a position in Anika Therapeutics in Q2 2014 and held it in 3 quarters.
  • Cornerstone Capital Management Holdings's Anika Therapeutics position peaked at $676K in Q2 2016.
  • 158 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.